Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel

NCT01863680 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

178

Enrollment

INDUSTRY

Sponsor class

Conditions

Luteal Hormone Supplementation in In-vitro Fertilization
Embryo Transfer

Interventions

DRUG: COL-1620
DRUG: Gonadotropin-releasing hormone (GnRH) analogue
DRUG: Follicle-stimulating hormone (FSH)
DRUG: Human Chorionic Gonadotropin (hCG)

Sponsor

Merck KGaA, Darmstadt, Germany